Evidence-Based Medicine

Issues of Concern

Evidence-based medicine brings together the best available evidence, clinical expertise, and patient values, but also has several limitations.[1][4] 

Publication Bias

EBM depends heavily on the published literature, yet published studies are not a neutral sample of all completed research. Positive findings are more likely to be published than negative or inconclusive results, and selective reporting can make benefits appear greater and harms appear less important than they really are. In meta-analyses, funnel plots may provide a visual clue to asymmetry that can suggest publication bias, although they are only one part of the assessment.[13][14][15]

Limitations of Randomized Controlled Trials

Randomized controlled trials are generally regarded as the highest level of primary study evidence, especially for questions of treatment efficacy.[16] Even so, not every important clinical question can be answered by a randomized trial. Rare diseases, ethical constraints, cost, and feasibility may make such studies impractical or inappropriate. Trial populations may also differ in important ways from the patients seen in routine practice, which can limit generalizability. The parachute example remains a useful reminder that not all valuable medical knowledge requires a randomized trial.[1][17]

Lag Time and Information Overload

Keeping current is increasingly difficult because the biomedical literature expands and digital tools multiply. Artificial intelligence (AI)-assisted tools may help with searching, screening, and summarizing the literature, but they can also introduce mistakes, including inaccurate or fabricated citations, and should not replace direct review of key sources.[8][9]

Patient Values and Clinical Judgment

Patient preferences are central to EBM, but they can be overshadowed in practice when clinicians focus too narrowly on protocols, guidelines, or statistically favorable outcomes. Strong evidence does not automatically identify the best choice for every patient. Clinical judgment is still needed to decide whether the evidence applies, and patient values remain essential when weighing burdens, trade-offs, and goals of care.[1][4][18]

Machine Learning as an Object of Evidence-Based Medicine Appraisal

Machine learning tools used for diagnosis, prognosis, triage, or decision support should be judged by the same EBM standards applied to other tests and prediction tools. Table 2 summarizes key questions for appraising clinical machine learning studies. Good performance metrics alone do not show that a model improves care. Validity, calibration, generalizability, and clinical usefulness still matter before a model should influence patient treatment.[10][11] Practical questions clinicians can use when appraising machine learning studies within the evidence-based medicine framework.[10][11]

Table 2. Criteria for Evidence-Based Medicine Evaluation of Clinical Machine Learning Studies

Clinical Significance

Evidence-based medicine is clinically important because it helps clinicians use the best available evidence in ways relevant to individual patients.[1][4] In practice, EBM matters because clinical decisions are rarely made on evidence alone. Diagnosis, prognosis, treatment, and prevention all require judgment about whether the available data fit the patient in front of the clinician. For example, a statistically favorable intervention may still be a poor choice if the patient’s comorbidities, baseline risk, goals, or treatment burden differ from those of the population studied. EBM helps clinicians move beyond habit, anecdote, or authority alone and toward decisions that are more transparent, more consistent, and more patient-centered.[1][18]

EBM is also important beyond the bedside. The framework provides the foundation for clinical practice guidelines, quality improvement efforts, and population-level recommendations. Modern frameworks such as Grading of Recommendations Assessment, Development and Evaluation Framework have improved this process by separating the certainty of evidence from the strength of the recommendation and by considering benefits, harms, patient values, and resource use, rather than study design alone.[12]

The significance of EBM has not diminished in the era of digital medicine and artificial intelligence. Instead, EBM has become more important. Clinicians now face a growing volume of literature, guidelines, prediction tools, and artificial intelligence (AI)-assisted decision-support systems. EBM remains the framework for deciding which of these tools are trustworthy, applicable, and clinically useful. Artificial intelligence may improve the efficiency of evidence retrieval, synthesis, and prediction, but its clinical value still depends on the same core questions: Is the information valid? Does the information apply to this patient? Is the information likely to improve care?[8][10][8][11]

Nursing, Allied Health, and Interprofessional Team Interventions

Evidence-based medicine is not limited to clinicians. Advanced practice clinicians, nurses, pharmacists, therapists, health coaches, athletic trainers, social workers, case managers, and other members of the interprofessional team all help put evidence into practice. Interprofessional team members identify clinical problems, help find and interpret relevant evidence, educate patients, monitor treatment response, and ensure patients’ goals and preferences are heard throughout the care team.[1][4][19]

Interprofessional application of evidence matters at the bedside because evidence rarely applies in exactly the same way to every patient. Nurses and advanced practice clinicians may be the first to notice worsening symptoms, poor treatment tolerance, low health literacy, cost barriers, limited support at home, or other factors that change whether an evidence-based recommendation is realistic. Pharmacists may identify drug interactions, safety concerns, or adherence problems. Therapists and other allied health professionals often add essential functional, behavioral, and practical context that strengthens clinical decision-making. EBM is often most useful when shared across the team rather than carried by a single clinician.[1][4]

The same caution applies to newer digital tools. As artificial intelligence (AI)-assisted prediction models and decision-support systems enter clinical workflows, care team members should interpret them using the same EBM principles applied to other clinical tools. Before prediction models and AI-assisted decision-support systems influence patient treatment, clinicians should ask whether the model was developed and reported transparently, whether it was validated in a relevant population, and whether it is likely to improve care in actual practice rather than simply perform well on paper.[8][10][11]

Nursing, Allied Health, and Interprofessional Team Monitoring

Monitoring closes the EBM cycle: the team assesses whether the chosen plan actually produced the intended outcome for this patient, not merely whether the plan was delivered. Monitoring works best when the team decides in advance what to track and over what interval, then watches for benefits that fail to materialize, harms that surface only with time, and shifts in the patient's condition, goals, or preferences that change which evidence still applies. When the clinical picture changes, the task is not only to adjust the plan but also to reconsider whether the original evidence still fits, including stepping back from an intervention once stronger or contradictory evidence emerges. Prediction models and AI-assisted tools warrant the same longitudinal scrutiny: their performance can drift because patient populations and practice patterns change, so continued accuracy and calibration should be rechecked over time rather than considered settled after adoption.[1][4][10][11][20]